Transgender Women’s Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs)-Reference-Cited by-同舟云学术

Transgender Women’s Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs)

Published:2019-10-25 Issue:5 Volume:24 Page:1452-1462
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Rael Christine Tagliaferri^ORCID,Martinez Michelle,Giguere Rebecca,Bockting Walter,MacCrate Caitlin,Mellman Will,Valente Pablo,Greene George J.,Sherman Susan G.,Footer Katherine H. A.,D’Aquila Richard T.,Carballo-Diéguez Alex,Hope Thomas J.

Funder

National Institute of Child Health and Human Development

Mac AIDS Fund

National Institute of Mental Health

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology

Link

http://link.springer.com/content/pdf/10.1007/s10461-019-02703-5.pdf

Reference58 articles.

1. Margolis DA, Stellbrink HJ, Eron JJ, Yazdanpanah Y, Griffith S, Dorey D, et al. Cabotegravir + Rilpivirine as long-acting maintenance therapy: LATTE-2 week 32 results. In: Margolis D, editor. Conference on Retroviruses and Opportunistic Infections (CROI); Boston2016.

2. Trezza C, Ford SL, Spreen W, Pan R, Piscitelli S. Formulation and pharmacology of long-acting cabotegravir. Curr Opin HIV AIDS. 2015;10(4):239–45.

3. Murray M, Markowitz M, Frank I, Grant RM, Mayer KH, Margolis DA, et al. Tolerability and acceptability of cabotegravir LA injection: Results from the ECLAIR study. Conference on Retroviruses and Opportunistic Infections (CROI); February 22-25; Boston, MA2016.

4. Andrews CD, Heneine W. Cabotegravir long-acting for HIV-1 prevention. Curr Opin HIV AIDS. 2015;10(4):258–63.

5. Pickett J. Presentation: Exploring the pipeline: Lubes, rings, films, fibers, and shots 4 HIV prevention. AIDS Foundation of Chicago. 2014;Accessed on 1/27/2017( http://www.slideshare.net/JimPickett/exploring-the-pipeline-lubes-rings-films-fibers-and-shots-4-hiv-prevention .).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study;Journal of the Association of Nurses in AIDS Care;2024-08-13

3. Long-Acting Injectable Pre-Exposure Prophylaxis Perceptions and Preferences Among Transgender and Nonbinary Young Adults in the United States;Qualitative Health Research;2024-08-02

4. Improving Recruitment and Retention of Transgender Women in HIV Prevention Trials: Strategies to Make Trial Participation More Congruent with the Needs of Transgender Women;AIDS Research and Human Retroviruses;2024-07-31

5. The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men and Physicians;AIDS Research and Human Retroviruses;2024-05-28